109 related articles for article (PubMed ID: 9561177)
1. Thromboxane A2 potentiates thrombin-induced proliferation of coronary artery smooth muscle cells.
Zucker TP; Bönisch D; Muck S; Weber AA; Bretschneider E; Glusa E; Schrör K
Adv Exp Med Biol; 1997; 433():387-90. PubMed ID: 9561177
[TBL] [Abstract][Full Text] [Related]
2. Thrombin-induced mitogenesis in coronary artery smooth muscle cells is potentiated by thromboxane A2 and involves upregulation of thromboxane receptor mRNA.
Zucker TP; Bönisch D; Muck S; Weber AA; Bretschneider E; Glusa E; Schrör K
Circulation; 1998 Feb; 97(6):589-95. PubMed ID: 9494030
[TBL] [Abstract][Full Text] [Related]
3. Effect of serotonin, thromboxane A2, and specific receptor antagonists on vascular smooth muscle cell proliferation.
Pakala R; Willerson JT; Benedict CR
Circulation; 1997 Oct; 96(7):2280-6. PubMed ID: 9337201
[TBL] [Abstract][Full Text] [Related]
4. Thromboxane A2 induces cell signaling but requires platelet-derived growth factor to act as a mitogen.
Grosser T; Zucker TP; Weber AA; Schulte K; Sachinidis A; Vetter H; Schrör K
Eur J Pharmacol; 1997 Jan; 319(2-3):327-32. PubMed ID: 9042608
[TBL] [Abstract][Full Text] [Related]
5. Angiopeptin, a somatostatin analogue, inhibits rat coronary artery and aorta smooth muscle cell proliferation induced by the thromboxane A2 mimetic U46619.
Zhao Y; Foegh ML
Prostaglandins; 1997 Nov; 54(5):781-93. PubMed ID: 9491208
[TBL] [Abstract][Full Text] [Related]
6. Effects of the dual TP receptor antagonist and thromboxane synthase inhibitor EV-077 on human endothelial and vascular smooth muscle cells.
Petri MH; Tellier C; Michiels C; Ellertsen I; Dogné JM; Bäck M
Biochem Biophys Res Commun; 2013 Nov; 441(2):393-8. PubMed ID: 24161392
[TBL] [Abstract][Full Text] [Related]
7. Synergistic interaction between thromboxane A2 and mildly oxidized low density lipoproteins on vascular smooth muscle cell proliferation.
Koba S; Pakala R; Watanabe T; Katagiri T; Benedict CR
Prostaglandins Leukot Essent Fatty Acids; 2000 Dec; 63(6):329-35. PubMed ID: 11133169
[TBL] [Abstract][Full Text] [Related]
8. Thromboxane A2/prostaglandin H2-stimulated mitogenesis of coronary artery smooth muscle cells involves activation of mitogen-activated protein kinase and S6 kinase.
Morinelli TA; Zhang LM; Newman WH; Meier KE
J Biol Chem; 1994 Feb; 269(8):5693-8. PubMed ID: 8119906
[TBL] [Abstract][Full Text] [Related]
9. Eicosapentaenoic acid and docosahexaenoic acid selectively attenuate U46619-induced smooth muscle cell proliferation.
Pakala R; Pakala R; Benedict C
Lipids; 1999 Sep; 34(9):915-20. PubMed ID: 10574655
[TBL] [Abstract][Full Text] [Related]
10. Dominant contribution of 5-hydroxytryptamine over thromboxane A2 in contractile response of rabbit isolated aortic preparation to thrombin activated platelets.
Nakanishi H; Matsuoka I; Ono T; Nakahata N
Res Commun Mol Pathol Pharmacol; 1995 Nov; 90(2):255-67. PubMed ID: 8747793
[TBL] [Abstract][Full Text] [Related]
11. Potentiation of PDGF-induced growth responses in coronary artery smooth muscle cells by thromboxane.
Zucker TP; Grosser T; Morinelli T; Halushka PV; Sachinidis A; Vetter H; Schrör K
Agents Actions Suppl; 1995; 45():53-8. PubMed ID: 7717201
[TBL] [Abstract][Full Text] [Related]
12. The effect of naftidrofuryl on PGF2 alpha, U 46.619, 5-HT and thromboxane A2 (TXA2) induced vasoconstriction.
Verheggen R; Schrör K
Biomed Biochim Acta; 1988; 47(10-11):S264-7. PubMed ID: 3248112
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the thromboxane (TP-) receptor subtype involved in proliferation in cultured vascular smooth muscle cells of rat.
Ko FN; Yu SM; Kang YF; Teng CM
Br J Pharmacol; 1995 Sep; 116(2):1801-8. PubMed ID: 8528563
[TBL] [Abstract][Full Text] [Related]
14. Thromboxane A2 stimulated signal transduction in vascular smooth muscle.
Dorn GW; Becker MW
J Pharmacol Exp Ther; 1993 Apr; 265(1):447-56. PubMed ID: 8474027
[TBL] [Abstract][Full Text] [Related]
15. Cloning, tissue-specific expression and regulation of the bovine thromboxane A2 receptor.
Muck S; Schrör K
Adv Exp Med Biol; 1997; 433():47-50. PubMed ID: 9561101
[No Abstract] [Full Text] [Related]
16. Effect of serotonin and thromboxane A2 on endothelial cell proliferation: effect of specific receptor antagonists.
Pakala R; Benedict CR
J Lab Clin Med; 1998 Jun; 131(6):527-37. PubMed ID: 9626988
[TBL] [Abstract][Full Text] [Related]
17. Thromboxane A2 fails to induce proliferation of smooth muscle cells enriched with eicosapentaenoic acid and docosahexaenoic acid.
Pakala R; Pakala R; Benedict CR
Prostaglandins Leukot Essent Fatty Acids; 1999 Apr; 60(4):275-81. PubMed ID: 10397410
[TBL] [Abstract][Full Text] [Related]
18. Activation of thromboxane and prostacyclin receptors elicits opposing effects on vascular smooth muscle cell growth and mitogen-activated protein kinase signaling cascades.
Jones DA; Benjamin CW; Linseman DA
Mol Pharmacol; 1995 Nov; 48(5):890-6. PubMed ID: 7476920
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneity of prostaglandin H2/thromboxane A2 receptors: distinct subtypes mediate vascular smooth muscle contraction and platelet aggregation.
Furci L; Fitzgerald DJ; Fitzgerald GA
J Pharmacol Exp Ther; 1991 Jul; 258(1):74-81. PubMed ID: 1830100
[TBL] [Abstract][Full Text] [Related]
20. Thromboxane A2-induced inhibition of voltage-gated K+ channels and pulmonary vasoconstriction: role of protein kinase Czeta.
Cogolludo A; Moreno L; Bosca L; Tamargo J; Perez-Vizcaino F
Circ Res; 2003 Oct; 93(7):656-63. PubMed ID: 12970114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
